Supriya Lifescience Limited (BOM:543434)

India flag India · Delayed Price · Currency is INR
728.15
+3.95 (0.55%)
At close: Jul 2, 2025
77.64%
Market Cap 59.18B
Revenue (ttm) 6.96B
Net Income (ttm) 1.88B
Shares Out n/a
EPS (ttm) 23.35
PE Ratio 31.49
Forward PE 29.93
Dividend 0.80 (0.11%)
Ex-Dividend Date Sep 20, 2024
Volume 10,107
Average Volume 17,504
Open 725.00
Previous Close 724.20
Day's Range 715.15 - 733.80
52-Week Range 368.60 - 841.70
Beta n/a
RSI 63.19
Earnings Date Jul 24, 2025

About Supriya Lifescience

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer det... [Read more]

Industry Pharmaceutical Preparations
Founded 1987
Employees 448
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543434
Full Company Profile

Financial Performance

In 2024, Supriya Lifescience's revenue was 6.96 billion, an increase of 22.11% compared to the previous year's 5.70 billion. Earnings were 1.88 billion, an increase of 57.80%.

Financial Statements

News

There is no news available yet.